{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:37:03Z","timestamp":1788871023103,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005277","name":"Presbyterian Historical Society","doi-asserted-by":"publisher","award":["HL41370"],"award-info":[{"award-number":["HL41370"]}],"id":[{"id":"10.13039\/100005277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005277","name":"Presbyterian Historical Society","doi-asserted-by":"publisher","award":["MH6410"],"award-info":[{"award-number":["MH6410"]}],"id":[{"id":"10.13039\/100005277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005277","name":"Presbyterian Historical Society","doi-asserted-by":"publisher","award":["NS14610"],"award-info":[{"award-number":["NS14610"]}],"id":[{"id":"10.13039\/100005277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.expneurol.2004.04.006","type":"journal-article","created":{"date-parts":[[2004,5,30]],"date-time":"2004-05-30T16:55:21Z","timestamp":1085936121000},"page":"292-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity"],"prefix":"10.1016","volume":"188","author":[{"given":"L.N.","family":"Boehmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-F.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.04.006_BIB1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.50.2_Suppl_1.S2","article-title":"Diagnostic aspects of narcolepsy","volume":"50","author":"Aldrich","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0166-2236(00)01948-2","article-title":"Neonatal glucocorticoids and the developing brain: short-term treatment with life-long consequences?","volume":"24","author":"Bakker","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0190-9622(82)70118-5","article-title":"Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions","volume":"7","author":"Barnhill","year":"1982","journal-title":"J. Am. Acad. Dermatol"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/tera.1420470203","article-title":"Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity","volume":"47","author":"Bian","year":"1993","journal-title":"Teratology"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB5","series-title":"Veterinary Pediatrics: Dogs and Cats from Birth to Six Months","first-page":"337","article-title":"Hematology of normal dogs and cats and responses to disease","author":"Bounous","year":"1995"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1176\/ajp.116.11.1030","article-title":"Sleep regulation with thalidomide","volume":"116","author":"Cohen","year":"1960","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1212\/WNL.39.1.140","article-title":"Monozygotic twins concordant for the narcoleptic syndrome","volume":"39","author":"Douglass","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/bjc.1994.364","article-title":"Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline","volume":"70","author":"Fredrikson","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB9","series-title":"Cecil Textbook of Medicine","year":"2000"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0306-4522(02)00089-1","article-title":"Cataplexy-related neurons in the amygdala of the narcoleptic dog","volume":"112","author":"Gulyani","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB11","first-page":"360","article-title":"Narcolepsy and HLA: positive DR2 as a prerequisite for the development of narcolepsy","volume":"38","author":"Honda","year":"1984","journal-title":"Folia Psychiatr. Neurol. Jpn"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-5793(98)01432-X","article-title":"Induction of outward current by orexin-B in mouse peritoneal macrophages","volume":"440","author":"Ichinose","year":"1998","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.expneurol.2004.04.006_BIB13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jnen\/60.10.1004","article-title":"Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation","volume":"60","author":"Ito","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB14","first-page":"8.2","article-title":"Developmental changes in hypocretin-1 (orexin-A) level in canine narcolepsy","volume":"27","author":"John","year":"2001","journal-title":"Soc. Neurosci. Abstr"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB15","first-page":"1205","article-title":"Effects of intraventricular methotrexate on cerebrospinal fluid monoamine metabolites in rhesus monkeys","volume":"70","author":"Johnston","year":"1986","journal-title":"Cancer Treat. Rep"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB16","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00001756-199608120-00002","article-title":"Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy","volume":"12","author":"Kanbayashi","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB17","first-page":"369","article-title":"Immunosuppression with cyclosporine as a treatment for canine narcolepsy","volume":"16","author":"Kilduff","year":"1987","journal-title":"Sleep Res"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The REM sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","article-title":"Thalidomide: a review of approved and investigational uses","volume":"25","author":"Matthews","year":"2003","journal-title":"Clin. Ther"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB20","first-page":"S16","article-title":"Genetic and familial aspects of narcolepsy","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB21","series-title":"Genetically Determined Animal Models of Neurobehavioral Dysfunction","first-page":"554","article-title":"Genetically determined animal models of narcolepsy, a disorder of REM sleep","author":"Mignot","year":"1992"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02244337","article-title":"Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers","volume":"113","author":"Mignot","year":"1993","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB23","series-title":"Narcolepsy","first-page":"387","article-title":"Toward an animal model of narcolepsy-cataplexy","author":"Mitler","year":"1976"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1212\/WNL.37.6.1089","article-title":"Narcolepsy in monozygotic twins","volume":"37","author":"Montplaisir","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB25","series-title":"HLA in Narcolepsy","first-page":"97","article-title":"HLA in narcolepsy in Canada","author":"Montplaisir","year":"1988"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(99)01336-0","article-title":"Distribution of orexin neurons in the adult rat brain","volume":"827","author":"Nambu","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB27","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/sleep\/17.suppl_8.S13","article-title":"Twin studies in narcolepsy","volume":"17","author":"Partinen","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB28","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/sleep\/13.4.336","article-title":"DR-2-positive monozygotic twins discordant for narcolepsy","volume":"13","author":"Pollmacher","year":"1990","journal-title":"Sleep"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/exnr.1998.6847","article-title":"Development of cataplexy in genetically narcoleptic dobermans","volume":"152","author":"Riehl","year":"1998","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB32","series-title":"Immunology","author":"Roitt","year":"2003"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ana.10444","article-title":"The neurobiology, diagnosis, and treatment of narcolepsy","volume":"53","author":"Scammell","year":"2003","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0092-8674(00)81969-8","article-title":"Narcolepsy: a key role for hypocretins (orexins)","volume":"98","author":"Siegel","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.1925546","article-title":"Neuronal activity in narcolepsy: identification of cataplexy related cells in the medial medulla","volume":"262","author":"Siegel","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB36","first-page":"1235","article-title":"Evidence for localized neuronal degeneration in the narcoleptic dog","volume":"21","author":"Siegel","year":"1995","journal-title":"Soc. Neurosci. Abstr"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1523\/JNEUROSCI.19-01-00248.1999","article-title":"Neuronal degeneration in canine narcolepsy","volume":"19","author":"Siegel","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/088307388600100406","article-title":"A model of methotrexate encephalopathy: neurotransmitter and pathologic abnormalities","volume":"1","author":"Silverstein","year":"1986","journal-title":"J. Child Neurol"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1203\/00006450-198604000-00002","article-title":"Cerebrospinal fluid biogenic amine metabolites in children during treatment for acute lymphocytic leukemia","volume":"20","author":"Silverstein","year":"1986","journal-title":"Pediatr. Res"},{"issue":"6\u20137","key":"10.1016\/j.expneurol.2004.04.006_BIB40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0960-8966(01)00198-5","article-title":"Do immune cells promote the pathology of dystrophin-deficient myopathies?","volume":"11","author":"Spencer","year":"2001","journal-title":"Neuromuscul. Disord"},{"issue":"2","key":"10.1016\/j.expneurol.2004.04.006_BIB41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/smrv.2001.0159","article-title":"Sleep and the hypothalamo-pituitary-adrenocortical system","volume":"6","author":"Steiger","year":"2002","journal-title":"Sleep Med. Rev"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB42","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1523\/JNEUROSCI.16-15-04588.1996","article-title":"Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in canine model","volume":"16","author":"Tafti","year":"1996","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB44","first-page":"A296","article-title":"Preservation of hypocretin neurons in genetically narcoleptic dogs","volume":"23","author":"Thannickal","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB45","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0306-4522(98)00600-9","article-title":"Locus coeruleus neurons: cessation of activity during cataplexy","volume":"91","author":"Wu","year":"1999","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.expneurol.2004.04.006_BIB46","doi-asserted-by":"crossref","first-page":"R1079","DOI":"10.1152\/ajpregu.00207.2002","article-title":"Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement","volume":"283","author":"Wu","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"key":"10.1016\/j.expneurol.2004.04.006_BIB47","first-page":"21","article-title":"Effect of neonatal corticoid treatment on tryptophan and serotonin metabolism","volume":"12","author":"Yuwiler","year":"1978","journal-title":"Endocrinol. Exp"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:33:58Z","timestamp":1758000838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488604001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0014488604001396"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.04.006","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}